IL33 and neoplasm: However, when Treg cells lack IL-33, the tumor microenvironment changes, causing the cells to transform into “fragile” Treg cells with considerably increased PD-1 expression, lower neuropilin-1 (Nrp-1) expression, and loss of IL-33’s inhibitory effect on NF-κB.